Cargando…
Factors affecting bone mineral density in multiple sclerosis patients
BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease which can cause many disabilities for the patient. Recent data suggests that MS patients have higher risk for osteoporosis. This study was performed to investigate if the osteoporosis prevalence is higher in MS patients and to determine...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829273/ https://www.ncbi.nlm.nih.gov/pubmed/24250892 |
_version_ | 1782291347241172992 |
---|---|
author | Ayatollahi, Azin Mohajeri-Tehrani, Mohammad Reza Nafissi, Shahriar |
author_facet | Ayatollahi, Azin Mohajeri-Tehrani, Mohammad Reza Nafissi, Shahriar |
author_sort | Ayatollahi, Azin |
collection | PubMed |
description | BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease which can cause many disabilities for the patient. Recent data suggests that MS patients have higher risk for osteoporosis. This study was performed to investigate if the osteoporosis prevalence is higher in MS patients and to determine the possible factors affecting bone mineral density (BMD). METHODS: 51 definite relapsing-remitting MS patients according to McDonald's criteria (45 females, 6 males aged between 20 and 50 years) participated in this study. The control group included 407 females aged from 20 to 49 years; they were healthy and had no history of the diseases affecting bone metabolism. Femoral and lumbar BMD were measured by Dual Energy X-ray Absorptiometry (DXA). The disability of MS patients was evaluated by Expanded Disability Status Scale (EDSS). The patient's quality of life was evaluated by the validated Persian version of multiple sclerosis impact scale (MSIS-29). RESULTS: Patients’ mean age was 36 ± 3.3 years and their mean disease duration was 8.7 ± 1.7 years. The mean EDSS score and the mean body mass index (BMI) of the patients were 3 ± 0.9 and 23.5 ± 2.3 kg/m(2), respectively. 29% of the patients had never been treated by ß-interferon and 6% of them had not received glucocorticoids (GCs) pulses since their MS had been diagnosed. 26% of the patients had a history of fracture.18% of our patients were osteoporotic and 43% of them were osteopenic. Femoral BMD was significantly lower among MS patients than age matched controls (P < 0.001), but lumbar BMD showed no difference. There was no correlation between administration of GCs pulses, interferon and BMD; however, we found a significant correlation between EDSS score, quality of life (QoL), disease duration and BMD of both site. CONCLUSION: As a result of this study, bone loss inevitably occurs in MS patients. The major factor of BMD loss is immobility. Osteoporosis should be managed as part of MS patients’ treatment protocols. |
format | Online Article Text |
id | pubmed-3829273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-38292732013-11-18 Factors affecting bone mineral density in multiple sclerosis patients Ayatollahi, Azin Mohajeri-Tehrani, Mohammad Reza Nafissi, Shahriar Iran J Neurol Original Paper BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease which can cause many disabilities for the patient. Recent data suggests that MS patients have higher risk for osteoporosis. This study was performed to investigate if the osteoporosis prevalence is higher in MS patients and to determine the possible factors affecting bone mineral density (BMD). METHODS: 51 definite relapsing-remitting MS patients according to McDonald's criteria (45 females, 6 males aged between 20 and 50 years) participated in this study. The control group included 407 females aged from 20 to 49 years; they were healthy and had no history of the diseases affecting bone metabolism. Femoral and lumbar BMD were measured by Dual Energy X-ray Absorptiometry (DXA). The disability of MS patients was evaluated by Expanded Disability Status Scale (EDSS). The patient's quality of life was evaluated by the validated Persian version of multiple sclerosis impact scale (MSIS-29). RESULTS: Patients’ mean age was 36 ± 3.3 years and their mean disease duration was 8.7 ± 1.7 years. The mean EDSS score and the mean body mass index (BMI) of the patients were 3 ± 0.9 and 23.5 ± 2.3 kg/m(2), respectively. 29% of the patients had never been treated by ß-interferon and 6% of them had not received glucocorticoids (GCs) pulses since their MS had been diagnosed. 26% of the patients had a history of fracture.18% of our patients were osteoporotic and 43% of them were osteopenic. Femoral BMD was significantly lower among MS patients than age matched controls (P < 0.001), but lumbar BMD showed no difference. There was no correlation between administration of GCs pulses, interferon and BMD; however, we found a significant correlation between EDSS score, quality of life (QoL), disease duration and BMD of both site. CONCLUSION: As a result of this study, bone loss inevitably occurs in MS patients. The major factor of BMD loss is immobility. Osteoporosis should be managed as part of MS patients’ treatment protocols. Tehran University of Medical Sciences 2013 /pmc/articles/PMC3829273/ /pubmed/24250892 Text en Copyright © 2013 Iranian Neurological Association, and Tehran University of Medical Sciences http://creativecommons.org/licenses/by/2.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Paper Ayatollahi, Azin Mohajeri-Tehrani, Mohammad Reza Nafissi, Shahriar Factors affecting bone mineral density in multiple sclerosis patients |
title | Factors affecting bone mineral density in multiple sclerosis patients |
title_full | Factors affecting bone mineral density in multiple sclerosis patients |
title_fullStr | Factors affecting bone mineral density in multiple sclerosis patients |
title_full_unstemmed | Factors affecting bone mineral density in multiple sclerosis patients |
title_short | Factors affecting bone mineral density in multiple sclerosis patients |
title_sort | factors affecting bone mineral density in multiple sclerosis patients |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829273/ https://www.ncbi.nlm.nih.gov/pubmed/24250892 |
work_keys_str_mv | AT ayatollahiazin factorsaffectingbonemineraldensityinmultiplesclerosispatients AT mohajeritehranimohammadreza factorsaffectingbonemineraldensityinmultiplesclerosispatients AT nafissishahriar factorsaffectingbonemineraldensityinmultiplesclerosispatients |